dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | De Stefano, Nicola |
dc.contributor.author | Montalban Gairín, Xavier |
dc.contributor.author | Achiron, Anat |
dc.contributor.author | Derfuss, Tobias |
dc.contributor.author | Chan, Andrew |
dc.contributor.author | Barkhof, Frederik |
dc.date.accessioned | 2022-09-12T08:25:22Z |
dc.date.available | 2022-09-12T08:25:22Z |
dc.date.issued | 2022-07 |
dc.identifier.citation | de Stefano N, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, et al. Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022 Jul;9(4):e1187. |
dc.identifier.issn | 2332-7812 |
dc.identifier.uri | https://hdl.handle.net/11351/8138 |
dc.description | Esclerosi múltiple recurrent activa; Imatge per ressonància magnètica; Cladribina |
dc.description.sponsorship | This study was supported by the healthcare business of Merck KGaA, Darmstadt, Germany (CrossRef Funder ID: 10.13039/100009945). |
dc.language.iso | eng |
dc.publisher | Lippincott Williams & Wilkins |
dc.relation.ispartofseries | Neurology - Neuroimmunology & Neuroinflammation;9(4) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Esclerosi múltiple - Imatgeria per ressonància magnètica |
dc.subject | Immunoteràpia |
dc.subject | Comprimits (Medicina) - Ús terapèutic |
dc.subject.mesh | Multiple Sclerosis |
dc.subject.mesh | /diagnostic imaging |
dc.subject.mesh | Magnetic Resonance Imaging |
dc.subject.mesh | Immunotherapy |
dc.title | Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1212/NXI.0000000000001187 |
dc.subject.decs | esclerosis múltiple |
dc.subject.decs | /diagnóstico por imagen |
dc.subject.decs | imagen por resonancia magnética |
dc.subject.decs | inmunoterapia |
dc.relation.publishversion | https://doi.org/10.1212/NXI.0000000000001187 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [de Stefano N] Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. [Barkhof F] Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands. UCL Institute of Neurology, London, UK. [Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Achiron A] Multiple Sclerosis Center, Sheba Academic Medical Center, Ramat Gan, Israel. [Derfuss T] Department of Neurology, University Hospital Basel, Basel, Switzerland. [Chan A] Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland |
dc.identifier.pmid | 35701185 |
dc.identifier.wos | 000816701200018 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |